What is physIQ?
physIQ operates at the intersection of advanced data science and clinical medicine, providing an enterprise-grade platform that processes continuous data from wearable biosensors. The company distinguishes itself through a rigorous commitment to regulatory validation, having developed one of the most comprehensive clinical study frameworks in the digital health space. Its technology is designed to empower pharmaceutical companies, health systems, and payers by converting complex physiological streams into high-fidelity health insights. By focusing on deep, AI-driven analytics, physIQ is effectively redefining the standard for remote patient monitoring and clinical trial support, moving beyond simple data collection to provide meaningful, evidence-based health intelligence.
How much funding has physIQ raised?
physIQ has raised a total of $19.9M across 5 funding rounds:
Series A
$4.6M
Private Equity
$3.6M
Series B
$8M
Unspecified
$3.3M
Debt
$350K
Series A (2014): $4.6M with participation from LionBird Ltd.
Private Equity (2016): $3.6M, investors not publicly disclosed
Series B (2017): $8M supported by 4490 Ventures, GF Securities, LionBird, and Quark Venture Inc.
Unspecified (2019): $3.3M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
Key Investors in physIQ
LionBird Ltd.
LionBird is a venture capital firm specializing in early-stage health-tech startups that aim to disrupt traditional healthcare models through innovative technology.
Quark Venture Inc.
Quark Venture focuses on equity financing for biotechnology companies, supporting breakthrough platforms that offer high-growth potential in the healthcare sector.
4490 Ventures
4490 Ventures provides strategic support and capital to high-growth companies, leveraging deep expertise in marketing and business development to drive market leadership.
What's next for physIQ?
With the recent influx of capital, physIQ is well-positioned to expand its footprint in the global digital medicine market. The strategic focus will likely center on deepening the integration of its AI-based analytics within existing healthcare infrastructures, thereby enhancing the scalability of its enterprise cloud platform. As the industry shifts toward value-based care and decentralized clinical trials, physIQ's ability to provide continuous, real-time physiological monitoring will be critical. Future growth initiatives will likely involve further regulatory milestones and the expansion of its partnership ecosystem, ensuring that its technology remains at the forefront of the digital health revolution.
See full physIQ company page
